Cargando…

P991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB

Detalles Bibliográficos
Autores principales: Harrington, P., Dillon, R., Radia, D., McLornan, D., Curto-Garcia, N., Woodley, C., Asirvatham, S., Kordasti, S., Harrison, C., de Lavallade, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429637/
http://dx.doi.org/10.1097/01.HS9.0000846832.56792.11
_version_ 1784779517578969088
author Harrington, P.
Dillon, R.
Radia, D.
McLornan, D.
Curto-Garcia, N.
Woodley, C.
Asirvatham, S.
Kordasti, S.
Harrison, C.
de Lavallade, H.
author_facet Harrington, P.
Dillon, R.
Radia, D.
McLornan, D.
Curto-Garcia, N.
Woodley, C.
Asirvatham, S.
Kordasti, S.
Harrison, C.
de Lavallade, H.
author_sort Harrington, P.
collection PubMed
description
format Online
Article
Text
id pubmed-9429637
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94296372022-08-31 P991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB Harrington, P. Dillon, R. Radia, D. McLornan, D. Curto-Garcia, N. Woodley, C. Asirvatham, S. Kordasti, S. Harrison, C. de Lavallade, H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429637/ http://dx.doi.org/10.1097/01.HS9.0000846832.56792.11 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Harrington, P.
Dillon, R.
Radia, D.
McLornan, D.
Curto-Garcia, N.
Woodley, C.
Asirvatham, S.
Kordasti, S.
Harrison, C.
de Lavallade, H.
P991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB
title P991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB
title_full P991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB
title_fullStr P991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB
title_full_unstemmed P991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB
title_short P991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB
title_sort p991: impairment of tcr signalling in patients with myelofibrosis treated with ruxolitinib
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429637/
http://dx.doi.org/10.1097/01.HS9.0000846832.56792.11
work_keys_str_mv AT harringtonp p991impairmentoftcrsignallinginpatientswithmyelofibrosistreatedwithruxolitinib
AT dillonr p991impairmentoftcrsignallinginpatientswithmyelofibrosistreatedwithruxolitinib
AT radiad p991impairmentoftcrsignallinginpatientswithmyelofibrosistreatedwithruxolitinib
AT mclornand p991impairmentoftcrsignallinginpatientswithmyelofibrosistreatedwithruxolitinib
AT curtogarcian p991impairmentoftcrsignallinginpatientswithmyelofibrosistreatedwithruxolitinib
AT woodleyc p991impairmentoftcrsignallinginpatientswithmyelofibrosistreatedwithruxolitinib
AT asirvathams p991impairmentoftcrsignallinginpatientswithmyelofibrosistreatedwithruxolitinib
AT kordastis p991impairmentoftcrsignallinginpatientswithmyelofibrosistreatedwithruxolitinib
AT harrisonc p991impairmentoftcrsignallinginpatientswithmyelofibrosistreatedwithruxolitinib
AT delavalladeh p991impairmentoftcrsignallinginpatientswithmyelofibrosistreatedwithruxolitinib